Hosted on MSN1d
Airbus A320 ATRA Performs Maiden Flight After E-Scan AESA Radar Modification
The Advanced Technology Research Aircraft is equipped with the nose of a Eurofighter to test the new E-Scan Mk1 AESA radar, ...
Atara Biotherapeutics: Another Dip Buying Opportunity Following CRL For CMC Issues
Atara Biotherapeutics has just announced a CRL by FDA for EBVALLO. Click here to read more about ATRA stock and why it is ...
Airforce Technology on MSN14h
Airbus’ A320 ATRA with Eurofighter nose completes first flight
Airbus has completion of a first flight for German Aerospace Center's (DLR) modified Airbus A320 ATRA for the E-Scan radar project.
news.stocktradersdaily4d
Trend Tracker for (ATRA)
Short ATRA slightly under 8.11, target 4.38, stop loss @ 8.13 Check the time stamp on this data. Updated AI-Generated Signals ...
Jane's Information Group1d
Airbus flies ATRA test aircraft modified for Eurofighter E-Scan radar
Airbus has flown the Advanced Technology Research Aircraft (ATRA) flight test aircraft (FTA) that has been modified for the ...
Flightglobal17h
Germany flies A320 testbed modified to carry Eurofighter’s ECRS Mk1 radar
Germany's DLR aerospace research centre has completed the first flight of an Airbus A320 adapted to conduct airborne testing ...
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Atara Biotherapeutics, Inc. (ATRA)
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Atara ...
Zacks.com on MSN6d
ATRA Stock Down After FDA Issues CRL for Rare Blood Cancer Candidate
Atara stock plunges 41% upon the FDA issuance of a CRL against its BLA for Ebvallo to treat EBV+ PTLD. The company is also facing a severe cash crunch.
Atara Biotherapeutics Faces Strategic Uncertainty Amid FDA Hold and CRL Issues
H.C. Wainwright analyst Robert Burns has reiterated their neutral stance on ATRA stock, giving a Hold rating yesterday.Invest with Confidence: ...
FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs
On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) ...
American Association of Individual Investors8d
Why Atara Biotherapeutics, Inc.’s (ATRA) Stock Is Down 40.50%
Atara Biotherapeutics, Inc.’s ATRA share price has dipped by 40.50%, which has investors questioning if this is right time to ...